Please login to the form below

Not currently logged in
Email:
Password:

New NHS specialist cancer unit

Cancer campaigners welcome policy to invest in the treatment of brain and spinal cord tumours

Cancer charities have welcomed a move by ministers in England to increase investment in specialist cancer care for brain and spinal cord tumours.

Under ministerial proposals, hospitals will be invited to bid to become the first national centre for proton therapy – a cancer treatment that uses radiation to attack cancerous cells while minimising damage to nearby tissue. It works by firing energy into the tumour where electrons damage the DNA of cancerous cells, killing them.

There is just one specialist unit in England and it treats only less complex eye cancers. Clatterbridge on the Wirral uses a low-energy machine that can only be used to reach cancers near the eye. As a result, many patients are forced to seek care abroad.

Proton therapy, which is most commonly used on children and patients with tumours near the most sensitive parts of the brain and spinal cord, is available in the US and other European countries. However, the cost of treatment can be in excess of £100,000.

The new unit in England would treat up to 400 patients each year.

Wendy Fulcher, chairman of cancer charity, Brain Tumour Research, welcomed the news, saying that she hopes the move will "signal a shift in policy for increased funding for brain tumour treatment and research".

19th August 2009

From: Healthcare

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CAN advertising

Brief us and you’ll soon see we really CAN do it all. We’re different to other agencies. You’ll get expert...

Latest intelligence

Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
ABPI2018
The NHS and ABPI at 70: inching closer to the triple win
The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....

Infographics